BRITTANY JANG: Open Payments
NPI 1063972339 · GREENBRAE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$862 in 26 payments from 14 companies in 2025. Trend: 2023 $1,246 · 2024 $1,033 · 2025 $862
Food & beverage: $862
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 6 | $193 |
| Ethicon US, LLC | 2 | $123 |
| ABBVIE INC. | 4 | $80 |
| Janssen Biotech, Inc. | 2 | $76 |
| MIMEDX Group, Inc. | 1 | $57 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $53 |
| Telix Pharmaceuticals | 2 | $50 |
| BIOTISSUE HOLDINGS INC. | 1 | $47 |
| Davol Inc. | 1 | $38 |
| UROGEN PHARMA, INC. | 1 | $37 |
Products named: GEMTESA, STRATAFIX, ERLEADA, PYLARIFY, ILLUCCIX, BOTOX, ARISTA, LUPRON DEPOT.
Industry payments across CA — which companies pay providers there.
